Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: Initial results

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2213-2215

  Cascales Campos, P ^a   Ramirez, P ^a   Gonzalez, R ^a   Febrero, B ^a   Pons, J A ^a   Miras, M ^a   Sanchez Bueno, F ^a   Robles, R ^a   Parrilla, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; TUMOR NECROSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; NECROSIS; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SPAIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WAITING LISTS;

EID: 80051683957     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.023     Document Type: Article

References (15)

1. F.Y. Yao, R. Hirose, and J.M. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505
2. F.Y. Yao, R.K. Kerlan Jr, and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819
3. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260
4. M. Pompili, V.G. Mirante, and G. Rondinara Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumour recurrence Liver Transpl 11 2005 1117
5. F.Y. Yao Liver transplantation for hepatocelular carcinoma: beyond the Milan criteria Am J Transplant 8 2008 1982
6. R. Adam, P. McMaster, and J.G. O'Grady Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry European Liver Transplant Association Liver Transpl 9 2003 1231
7. J. Qiu, M. Ozawa, and P.I. Terasaki Liver transplantation in the United States Clin Transpl 17 2005 28
8. P.A. Cascales Campos, P.R. Romero, and R. Gonzalez Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma Transplant Proc 42 2010 627
9. K. Takayasu, S. Arii, and N. Matsuo Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR 175 2000 699
10. Y.S. Guan, L. Sun, and X.P. Zhou Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up World J Gastroenterol 10 2004 3543
11. L.G. Strauss, and P.S. Conti The applications of PET in clinical oncology J Nucl Med 32 1991 623
12. S. Okazumi, K. Isono, and K. Enomoto Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumour and assessment of effect of treatment J Nucl Med 33 1992 333
13. M.A. Khan, C.S. Combs, and E.M. Brunt Positron emission tomography scanning in the evaluation of hepatocellular carcinoma J Hepatol 32 2000 792
14. Y.K. Chen, D.S. Hsieh, and C.S. Liao Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence Anticancer Res 25 2005 4719
15. B. Böhm, M. Voth, and J. Geoghegan Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors J Cancer Res Clin Oncol 130 2004 266